BALAXI PHARMACEUTICALS LIMITED (BALAXI) — Long-term Investment Intensity
BALAXI PHARMACEUTICALS LIMITED (BALAXI) has a Long-term Investment Intensity of 0.1% as of March 2018. Long-term investments of Rs10.50K represent 0.1% of total assets of Rs16.87 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check cash flow reinvestment rate of BALAXI PHARMACEUTICALS LIMITED to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
BALAXI PHARMACEUTICALS LIMITED Long-term Investment Intensity (2016–2018)
This chart shows how BALAXI PHARMACEUTICALS LIMITED's Long-term Investment Intensity has evolved across 3 annual periods from 2016 to 2018. As of March 2018, the intensity stands at 0.1%, reflecting long-term investments of Rs10.50K against total assets of Rs16.87 Million INR. Explore BALAXI PHARMACEUTICALS LIMITED debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for BALAXI PHARMACEUTICALS LIMITED (2016–2018)
The table below presents the year-by-year Long-term Investment Intensity for BALAXI PHARMACEUTICALS LIMITED from 2016 to 2018, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see BALAXI PHARMACEUTICALS LIMITED (BALAXI) total market value.
| Year | LT Investment Intensity | LT Investments (INR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 0.1% | Rs10.50K | Rs16.87 Million | ▲ +0.0 pp |
| 2017 | 0.1% | Rs15.00K | Rs25.77 Million | ▼ -9170.1 pp |
| 2016 | 9170.1% | Rs32.74 Million | Rs356.99K | — |